NCT00316732 - Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS | Biotech Hunter

Enrollment

173

Participants

Timeline

Start Date

October 25, 2004

Primary Completion Date

December 19, 2006

Study Completion Date

December 19, 2006

Conditions

Prostatic Hyperplasia

Interventions

PROCEDURE

IPSS Questionnaire

PROCEDURE

EQ-5D Questionnaire

Trial Locations (27)

EX2 5DW

GSK Investigational Site, Exeter

PL6 8DH

GSK Investigational Site, Plymouth

CO4 5JL

GSK Investigational Site, Colchester

SG2 4AB

GSK Investigational Site, Stevenage

M13 9WL

GSK Investigational Site, Manchester

M8 5RB

GSK Investigational Site, Manchester

LE5 4PW

GSK Investigational Site, Leicester

E11 1NR

GSK Investigational Site, Leytonstone

EN2 8JL

GSK Investigational Site, Enfield

NG5 1PB

GSK Investigational Site, Nottingham

TA1 5DA

GSK Investigational Site, Tauton

SR4 7TP

GSK Investigational Site, Sunderland

B75 7RR

GSK Investigational Site, Sutton Coldfield

B15 2TH

GSK Investigational Site, Birmingham

BD5 0NA

GSK Investigational Site, Bradford

BD9 6RJ

GSK Investigational Site, Bradford

BS2 8HW

GSK Investigational Site, Bristol

G75 8RG

GSK Investigational Site, East Kilbride

HU16 5JD

GSK Investigational Site, Hull

DE7 8LN

GSK Investigational Site, Ilkeston, Derbyshire

LS1 3EX

GSK Investigational Site, Leeds

EC1 7BE

GSK Investigational Site, London

NW3 2QG

GSK Investigational Site, London

W18 6BJ

GSK Investigational Site, London

S10 2JF

GSK Investigational Site, Sheffield

TQ2 7AA

GSK Investigational Site, Torquay

WF1 4DG

GSK Investigational Site, Wakefield